How can I invest in health wearable devices and fitness tracking technology?

This blog post has been written by the person who has mapped the health wearables and fitness tracking market in a clean and beautiful presentation

The health wearables market has evolved from simple step counters to sophisticated medical-grade devices powered by AI and advanced biosensors. This transformation presents unprecedented opportunities for investors and entrepreneurs looking to enter a rapidly expanding sector worth billions.

And if you need to understand this market in 30 minutes with the latest information, you can download our quick market pitch.

What exactly are health wearable devices and fitness tracking technologies, and which specific segments are growing fastest right now?

Health wearables are body-worn electronic devices that continuously monitor physiological signals including heart rate, activity levels, sleep patterns, glucose levels, and ECG data, transmitting information via Bluetooth, cellular, or NFC connections.

The fastest-growing segments show remarkable expansion rates that far exceed traditional fitness trackers. Smart clothing and e-textiles lead with a 25.8% CAGR through 2032, driven by AI-integrated fabrics that can monitor multiple biomarkers simultaneously. These textile-based sensors are particularly valuable for athletes and medical patients requiring continuous monitoring without the bulk of traditional devices.

Smart insoles and leg-wear follow closely at 22.3% CAGR, capitalizing on enhanced gait analytics and elderly fall prevention applications. The aging population's need for mobility monitoring creates a substantial addressable market, with reimbursement potential through Medicare and insurance providers. Smart rings, exemplified by Oura's success, maintain 20.3% growth by targeting sleep optimization and nocturnal health monitoring—a niche that traditional wrist-worn devices struggle to serve effectively.

Continuous glucose monitoring represents the most clinically validated segment at 15.7% CAGR, benefiting from recent over-the-counter approvals that expand beyond diabetic patients to include wellness-focused consumers interested in metabolic optimization.

Need a clear, elegant overview of a market? Browse our structured slide decks for a quick, visual deep dive.

Who are the top startups and companies currently dominating or disrupting this space, and what are their core technologies or differentiators?

The competitive landscape divides between established tech giants leveraging ecosystem advantages and specialized startups pioneering breakthrough technologies in specific verticals.

If you want fresh and clear data on this market, you can download our latest market pitch deck here

What are the main business models these companies use to generate revenue—hardware sales, subscription models, data monetization, B2B services?

Health wearable companies employ diversified revenue strategies that extend far beyond traditional hardware sales, creating multiple income streams and higher customer lifetime values.

Hardware sales remain the primary revenue source for most companies, but the model has evolved toward premium pricing with advanced features. Apple commands $400-800 per device with regular upgrade cycles, while Oura prices its smart ring at $299-399 with a focus on durable, long-term usage. The key differentiator lies in the accompanying software ecosystem rather than hardware margins alone.

Subscription models provide recurring revenue and higher margins, with companies like Oura generating $5.99 monthly from premium analytics, personalized insights, and extended data history. Abbott's FreeStyle Libre View platform offers cloud-based data management and telehealth integration for healthcare providers, creating B2B subscription revenue streams that complement consumer device sales.

Data monetization represents the most controversial yet potentially lucrative model, where anonymized health insights are sold to insurers, pharmaceutical companies, and employers for wellness program optimization. Companies must navigate strict privacy regulations while demonstrating clear value to data purchasers through population health trends and intervention effectiveness metrics.

B2B services increasingly drive growth for specialized players like Kinetic, which contracts directly with industrial employers to reduce workplace injuries through predictive analytics. These enterprise relationships often involve multi-year contracts worth millions of dollars, providing predictable revenue and expansion opportunities across corporate client networks.

Which of these companies or startups are open to investment, either privately or through public markets, and under what terms or stages?

Investment opportunities span from late-stage private companies preparing for IPOs to growth-stage startups seeking Series B and C funding for market expansion.

Oura represents the most prominent late-stage opportunity, having raised $275 million in Series E funding with a $2.5 billion valuation. The company's path toward public markets appears likely within the next 18-24 months, given its strong revenue growth and market-leading position in smart rings. Early investors include Tiger Global and SoftBank Vision Fund, indicating institutional confidence in the category.

Growth-stage companies actively fundraising include several specialized players targeting specific verticals. Profusa continues raising capital for its implantable biosensor technology, having secured $145.5 million to advance clinical trials and regulatory approvals. Their focus on continuous multi-biomarker monitoring positions them for potential acquisition by larger medical device companies.

Industrial wearables present attractive B2B investment opportunities, with Kinetic's recent $176.6 million Series B demonstrating investor appetite for enterprise-focused solutions. RealWear's $100.2 million Series C targets voice-controlled industrial smart glasses, addressing a specific niche with clear ROI metrics and enterprise customer validation.

Public market opportunities include established players like Abbott (ABT), Garmin (GRMN), and Apple (AAPL), though these require larger capital commitments and offer less explosive growth potential. Investors seeking exposure without direct startup investment can access the sector through specialized ETFs or venture capital funds focused on digital health and wearable technologies.

What notable fundraising rounds have taken place so far in 2025 in this sector, and what valuation trends are emerging from them?

2025 has witnessed significant funding activity in health wearables, with total investment exceeding $800 million across multiple rounds, indicating strong investor confidence in the sector's long-term prospects.

• Kinetic - $176.6 million Series B: Industrial safety wearables with AI-powered injury prevention, demonstrating enterprise willingness to pay premium prices for measurable safety ROI
• Profusa - $145.5 million Series C: Implantable biosensors advancing toward FDA approval, with valuation reflecting regulatory risk but massive market potential
• LAFORGE Optical - $105.7 million Series C: Prescription AR eyewear combining vision correction with computing capabilities, targeting both consumer and enterprise markets
• RealWear - $100.2 million Series C: Voice-controlled industrial smart glasses with hands-free computing for manufacturing and field service applications
• Empatica - $41.7 million total funding: Medical-grade seizure monitoring devices with FDA clearance, focusing on neurological condition management

Valuation trends show premium pricing for companies with regulatory clearances, proven clinical outcomes, and B2B revenue models. Medical-grade devices command higher multiples than consumer wellness products, reflecting lower customer acquisition costs and reimbursement pathway potential. Enterprise-focused wearables achieve 10-15x revenue multiples compared to 5-8x for consumer-only companies.

Wondering who's shaping this fast-moving industry? Our slides map out the top players and challengers in seconds.

Are there particular use cases or customer segments that are underserved or particularly lucrative right now?

Several high-value customer segments remain significantly underserved, presenting substantial opportunities for focused startups and strategic investors.

Seniors and chronic disease patients represent the most lucrative underserved market, with aging populations requiring continuous monitoring but often struggling with complex technology interfaces. Companies developing simplified devices for elderly users, particularly those with fall prevention capabilities and emergency response integration, can command premium pricing through insurance reimbursement and family member peace-of-mind purchases.

Women's health monitoring represents another underexplored vertical, with hormonal cycle tracking, pregnancy monitoring, and menopause management offering subscription revenue opportunities. The femtech market's growth, combined with increasing healthcare focus on women-specific conditions, creates space for specialized wearable solutions that existing fitness trackers inadequately address.

Pediatric health monitoring presents regulatory challenges but enormous potential, with parents willing to pay premium prices for infant and child health tracking. Smart socks for newborns, non-invasive glucose monitoring for diabetic children, and development tracking devices can achieve high customer lifetime values through extended family usage patterns.

Mental health and stress management applications, while gaining attention, remain technically challenging to implement effectively. Companies that can provide validated stress monitoring, anxiety detection, and intervention recommendations through wearable technology will capture significant market share in the expanding digital therapeutics sector.

Athletes and sports science applications continue evolving beyond basic performance tracking toward injury prevention, recovery optimization, and biomechanical analysis. Professional sports teams and elite athletes represent high-value customers willing to invest heavily in performance advantages that wearable technology can provide.

If you need to-the-point data on this market, you can download our latest market pitch deck here

How do the regulatory requirements impact innovation, go-to-market timelines, and investment risks?

Regulatory frameworks significantly influence product development cycles, market entry strategies, and investment risk profiles, with medical-grade devices facing substantially longer timelines but achieving higher defensibility once approved.

FDA approval requirements add 12-24 months to go-to-market timelines for medical-grade devices, requiring extensive clinical trials, safety documentation, and efficacy validation. Companies pursuing FDA clearance must budget $2-5 million for regulatory processes, but successful approval enables reimbursement pathways and provides competitive moats that wellness-only devices cannot achieve.

European CE marking and GDPR compliance create additional complexity for companies targeting international markets, particularly regarding data privacy and cross-border health information transfer. The regulatory divergence between regions forces companies to choose between global ambitions and focused market entry strategies, affecting both development costs and investor expectations.

Consumer wellness devices can reach market faster by avoiding medical claims, but face limitations in pricing power and customer acquisition channels. The distinction between wellness and medical devices increasingly blurs as technology advances, creating opportunities for companies to start with wellness positioning and evolve toward medical applications as clinical evidence accumulates.

Investment risk varies dramatically based on regulatory pathway choice, with medical device investments requiring longer capital deployment periods but offering higher exit valuations. Investors must balance regulatory risk against market potential, often preferring companies with clear regulatory strategies and experienced development teams.

What are the main technology enablers driving next-generation innovation?

Advanced technology integration transforms wearables from simple sensors into sophisticated health monitoring platforms capable of real-time analysis and predictive insights.

Artificial intelligence and edge computing enable on-device processing that reduces cloud dependency while providing immediate feedback to users. Modern wearables incorporate machine learning algorithms that adapt to individual patterns, detecting anomalies in real-time without requiring constant internet connectivity. This technological shift reduces data privacy concerns while improving battery life and response times.

Advanced biosensors represent the core innovation driver, with companies like Profusa developing implantable sensors that monitor multiple biomarkers simultaneously. Non-invasive glucose monitoring, continuous hydration tracking, and real-time stress hormone detection expand monitoring capabilities beyond traditional heart rate and activity measurements. Sensor miniaturization and improved accuracy create opportunities for integration into clothing, accessories, and everyday objects.

Cloud platforms and API ecosystems facilitate data integration with electronic health records, telehealth platforms, and healthcare provider systems. Companies building robust data infrastructure can serve as aggregation points for multiple device types, creating network effects and improving overall health insights through comprehensive data analysis.

Low-energy connectivity technologies, including Bluetooth LE and NB-IoT, enable extended battery life while maintaining continuous data transmission capabilities. These improvements make wearables more practical for elderly users and chronic disease patients who require reliable, long-term monitoring without frequent device maintenance.

Looking for the latest market trends? We break them down in sharp, digestible presentations you can skim or share.

What kind of partnerships are these companies forming with healthcare providers, insurers, or tech platforms, and how do these affect scalability or exits?

Strategic partnerships increasingly determine company success, with healthcare ecosystem integration providing scalability advantages and exit value enhancement that pure-play hardware companies cannot achieve.

Healthcare provider partnerships focus on remote patient monitoring and chronic disease management, with companies like Abbott integrating FreeStyle Libre data directly into electronic health record systems. These relationships reduce customer acquisition costs while providing clinical validation that supports reimbursement claims and physician adoption. Successful partnerships often lead to acquisition opportunities as healthcare systems seek to internalize successful digital health solutions.

Insurance company collaborations create direct reimbursement pathways and population health management opportunities. Devices that demonstrate measurable health outcomes and cost reduction can achieve preferred formulary status, dramatically expanding addressable markets beyond direct-pay consumers. Insurance partnerships also provide access to large customer bases and marketing support that individual companies struggle to replicate independently.

Technology platform integrations with Apple HealthKit, Google Health, and other ecosystem players provide distribution advantages but create dependency risks. Companies must balance platform partnerships with maintaining direct customer relationships, as platform changes can significantly impact business models and customer access.

Corporate wellness partnerships represent high-value B2B opportunities, with employers purchasing devices and services for employee health programs. These relationships often involve multi-year contracts and provide predictable revenue streams that investors value highly during exit evaluations. Successful corporate wellness programs also generate case studies and ROI data that support expansion into similar market segments.

If you want to build or invest on this market, you can download our latest market pitch deck here

What competitive threats exist from big players like Apple, Google, Amazon, or Samsung, and how should an investor think about defensibility in this space?

Big tech companies pose significant competitive threats through ecosystem integration, distribution advantages, and virtually unlimited R&D budgets, but specialized startups maintain defensibility through focused innovation and regulatory expertise.

Apple's competitive advantage lies in seamless integration across devices, with HealthKit providing comprehensive health data aggregation that smaller companies cannot replicate. The company's massive user base and regular upgrade cycles create natural distribution channels that startups struggle to access. However, Apple's broad focus limits deep specialization in specific medical conditions or niche applications where focused companies can excel.

Google and Amazon leverage cloud computing capabilities and AI expertise to provide backend infrastructure that wearable companies often cannot develop independently. Their platforms offer data analysis and storage capabilities that enable smaller companies to focus on hardware and customer experience rather than building comprehensive technology stacks.

Samsung and other hardware manufacturers compete directly on device functionality and pricing, but lack the software ecosystem depth that creates customer stickiness. Their competition primarily affects commodity fitness tracker markets rather than specialized medical device applications.

Defensible moats for smaller companies include proprietary algorithms validated through clinical trials, exclusive regulatory clearances that require years of development, and specialized applications that big tech companies view as too small to address directly. Companies serving enterprise customers or specific medical conditions often maintain competitive advantages through deep domain expertise and customer relationships that large platforms cannot easily replicate.

Planning your next move in this new space? Start with a clean visual breakdown of market size, models, and momentum.

What are the forecasts or strategic moves expected in 2026, including emerging markets, product categories, or acquisition trends?

2026 forecasts indicate significant market consolidation, international expansion, and product category convergence as the wearables industry matures toward mainstream healthcare adoption.

Emerging markets, particularly in Asia-Pacific regions, represent the highest growth potential as smartphone penetration and disposable income increase. China's local original equipment manufacturers are scaling e-textile production capabilities, potentially disrupting Western companies' cost structures. India and Southeast Asia offer large addressable markets for simplified, cost-effective devices targeting diabetes management and maternal health monitoring.

Product category convergence will accelerate, with continuous glucose monitoring integration into mainstream smartwatches becoming standard rather than specialized. Metabolic health dashboards combining glucose, activity, and sleep data will create comprehensive wellness platforms that replace multiple single-purpose devices. Smart clothing integration will advance from niche athletic applications toward mainstream medical monitoring for elderly and chronic disease populations.

Acquisition activity will intensify as large medical device companies and technology firms acquire specialized startups to fill capability gaps. Companies with FDA clearances and proven clinical outcomes will command premium valuations, while early-stage startups may face increased competition for funding as investors focus on later-stage opportunities with clearer paths to profitability.

Artificial intelligence integration will become mandatory rather than optional, with companies unable to provide personalized insights and predictive analytics struggling to compete. Edge computing capabilities will expand to enable real-time health emergency detection and intervention, particularly for elderly monitoring and chronic disease management applications.

What are the most actionable next steps to get involved as an investor—joining syndicates, sourcing deal flow, evaluating pitch decks, or connecting with founders?

Successful health wearables investment requires systematic approach combining industry expertise development, deal flow access, and portfolio diversification across multiple stages and application areas.

• Join specialized syndicates: Focus on digital health and wearables-specific investment groups like Rock Health, HealthX Ventures, and Andreessen Horowitz Bio Fund, which provide deal access and due diligence support
• Source deal flow systematically: Attend industry events including CES Health Tech, Health 2.0, and Wearable Technology Show to meet founders and identify emerging trends before they reach mainstream investor attention
• Develop evaluation frameworks: Create standardized criteria for assessing regulatory pathway clarity, clinical validation strength, addressable market size, and competitive differentiation when reviewing pitch decks
• Build founder networks: Use platforms like AngelList, F6S, and LinkedIn to connect with entrepreneurs, while engaging with corporate venture arms from Johnson & Johnson, Merck, and Philips for co-investment opportunities
• Focus on defensible niches: Target companies with clear regulatory pathways, validated clinical outcomes, and B2B revenue models rather than consumer wellness applications with limited barriers to entry

Investors should prioritize late-stage companies with proven traction and regulatory clearances while maintaining small positions in earlier-stage companies developing breakthrough technologies. Portfolio construction should balance risk across consumer wellness applications, medical device developments, and enterprise solutions to capture multiple growth vectors within the expanding wearables ecosystem.

Conclusion

Sources

1. KMS Healthcare - Wearable Technology in Healthcare
2. Allied Market Research - Wearable Fitness Trackers Market
3. Future Market Insights - Continuous Glucose Monitoring Systems Market
4. Roots Analysis - Smart Clothing Market
5. Globe Newswire - Smart Clothing Market Research
6. Mordor Intelligence - Fitness Tracker Market
7. Business Insider - Wearable Technology and Remote Monitoring Startups
8. Quick Market Pitch - Wearable Technology Funding
9. Seedtable - Best Wearables Startups